VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S351000, C546S255000, C546S300000

Reexamination Certificate

active

10866078

ABSTRACT:
Novel VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones and their use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are selected.

REFERENCES:
patent: 6548548 (2003-04-01), Campbell et al.
patent: 2004/0039019 (2004-02-01), Huth et al.
patent: 2004/0102441 (2004-05-01), Krueger et al.
patent: 10023486 (2002-03-01), None
patent: 10228090 (2004-01-01), None
patent: WO 0027819 (2000-05-01), None
patent: WO 0027820 (2000-05-01), None
patent: WO 02090352 (2002-11-01), None
patent: WO 03040102 (2003-05-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3746421

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.